(Q48783638)

15 February 2018

review article

1 reference

title

Rivastigmine. A review of its use in Alzheimer's disease (English)

1 reference

15 February 2018

0 references

C M Spencer

1

1 reference

15 February 2018

S Noble

series ordinal

2

1 reference

15 February 2018

publication date

1 November 1998

1 reference

15 February 2018

published in

Drugs & Aging

1 reference

15 February 2018

volume

13

1 reference

15 February 2018

issue

5

1 reference

15 February 2018

page(s)

391-411

1 reference

15 February 2018

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease

cites work

1 reference

12 December 2020

Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

1 reference

12 December 2020

Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

1 reference

12 December 2020

Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man.

1 reference

12 December 2020

Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease.

1 reference

12 December 2020

Pharmacologic and Clinicopharmacologic Properties of SDZ ENA 713, a Centrally Selective Acetylcholinesterase Inhibitor

1 reference

12 December 2020

Alzheimer disease, attention, and the cholinergic system

1 reference

12 December 2020

Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.

1 reference

12 December 2020

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

12 December 2020

Post-ischemic administration of the acetylcholinesterase inhibitor ENA-713 prevents delayed neuronal death in the gerbil hippocampus.

1 reference

12 December 2020

Chronic administration of acetylcholinesterase inhibitor in the senescent rat brain

1 reference

12 December 2020

Effects of the acetylcholinesterase inhibitor ENA-713 on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain

1 reference

12 December 2020

A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease

1 reference

12 December 2020

Pharmacological evaluation of phenyl-carbamates as CNS-selective acetylcholinesterase inhibitors

1 reference

12 December 2020

Cognitive enhancement therapy for Alzheimer's disease. The way forward

1 reference

12 December 2020

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

12 December 2020

Effects of SDZ ENA 713, novel acetyl cholinesterase inhibitor, on learning of rats with basal forebrain lesions.

1 reference

12 December 2020

Inhibition of acetylcholinesterase modulates the autoregulation of cerebral blood flow and attenuates ischemic brain metabolism in hypertensive rats

1 reference

12 December 2020

Butyrylcholinesterase in the life cycle of amyloid plaques

1 reference

12 December 2020

Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.

1 reference

12 December 2020

Long-term tacrine treatment in patients with Alzheimer's disease

1 reference

12 December 2020

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

1 reference

12 December 2020

Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association

1 reference

12 December 2020

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

1 reference

12 December 2020

Cerebro-protective effects of ENA713, a novel acetylcholinesterase inhibitor, in closed head injury in the rat.

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

A new rating scale for Alzheimer's disease.

1 reference

12 December 2020

10.2165/00002512-199813050-00005

Identifiers

DOI

1 reference

15 February 2018

Dimensions Publication ID

1007518455

0 references

1 reference

15 February 2018